Oxford Technology Management — Full Portfolio

Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer.

BiotechHealthtechMedical Devices

EBEdward Bruce-White(CEO/Co-Founder)inAMAlberto Martinez Albalat(Director of R&D, Founder and Chairman)

Co-investorsNWNW Angel

Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage.

BiotechHealthtechMedical Devices

Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.

AI & Machine LearningBiotechMedical DevicesOxford, GB

AHAndreas Halner(Founder and Head of Healthcare AI)inHRHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in

Co-investorsEKEka VenturesCRCross-Border Impact VenturesMEMeridian Health VenturesUKUK Innovation & Science Seed FundCICivilization Ventures Management, LlcDIDigitalDx Ventures+1 more

Accelerated Diagnostics is developing decentralised diagnostics for human and veterinary markets, with a product launch planned for July 2026.

BiotechHealthtechMedical DevicesManchester, GB

Atelerix develops patented alginate hydrogel technology that stabilises cells, tissues, blood products, viruses and vectors at room temperature, removing the need for cryopreservation and cold-chain shipping.

BiotechDeep TechLogistics & Supply ChainMedical DevicesNew MaterialsNewcastle, GB

SSSteve Swioklo(Co-Founder & CSO)inChe Connon(Co-Founder (research lead))Alastair Carrington(CEO)

Co-investorsCACambridge Angels groupFUFuture Planet CapitalO2O2h VenturesUKUK Innovation & Science Seed Fund

Beyond Fence provides ISO-compliant safety solutions for industrial robotics and automation, focused on keeping human operators safe and in control while improving efficiency.

Advanced ManufacturingHardwareRoboticsOxford, GB

LYLuc Yao, MBA, MSc(Managing Director)

Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment.

AI & Machine LearningBiotechDeep TechHealthtech

GHGeoff Hale(Founder, Chairman)inLWLili Wang(Scientific Advisor & Co-founder)inHannah Chen(Scientific Advisor & Co-founder)

MyCelsius makes a wearable cooling bracelet designed to relieve hot flushes and night sweats by cooling the thermally sensitive inside of the wrist, with additional warming modes.

FemTechHardwareWellness & Fitness

Covatic develops an on-device advertising platform powered by AI and machine learning that identifies user cohorts and delivers targeted ads while preserving consumer privacy.

AdTechAI & Machine LearningIoTLondon, GB

NPNick Pinks(Founder)in

Co-investorsCRCreative UKTETechstarsOXOxford Science EnterprisesTETechstars Ventures 2022

Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer.

BiotechHealthtechMedical DevicesLondon, GB

DJDr Jeff Moore(Founder & CEO)

Co-investorsATAtlas VentureBIBiotechnology Value FundCACanaan PartnersPRProspect Venture Partners

Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation.

BiotechDeep TechMedical DevicesCoventry, GB

DJDr. James Stratford(Co-Founder & CTO)DMDr. Munehiro Asally(Academic Co-Founder)

digiLab builds AI and uncertainty quantification technology to help organisations and governments make decisions in high-stakes, safety-critical domains such as energy, critical infrastructure, cybersecurity, and environment when data is sparse or uncertain.

AI & Machine LearningDeep TechEnterprise Software

TDTim Dodwell(Co-Founder & CEO)inASAnhad Sandhu(Co-Founder & GM Saudi)inACAndrew Corbett(Director of AI)inRSRory Scott Russell(Chief Growth Officer)in

BoardNigel Toon(Chairman)

Digistain develops imaging technology to grade breast cancer biopsies and assess cancer recurrence risk faster and more cost-effectively than traditional methods.

AI & Machine LearningHealthtechMedical DevicesLondon, GB

HAHemmel Amrania(Founder)inCPChris Phillips(Founder)inWHWilliam Hart(Fractional CTO)in

Co-investorsGAGaingelsY Y Combinator

Entia develops at-home blood monitoring solutions for healthcare providers and patients.

Digital HealthHealthtechMedical Devices

DTDr Toby Basey-Fisher(CEO & Founder)

Co-investorsSUSussex Place VenturesPAParkwalk Advisors

Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool.

AI & Machine LearningBiotechDeep TechHarwell, Oxfordshire, GB

Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface for discovering and designing therapeutic biologics such as antibodies and TCRs.

AI & Machine LearningBiotechDeep Tech

Michelle Teng(Founder)

Flarebright develops patented software and machine learning technologies that add capabilities such as autonomous flight and flight safety systems to robotic and crewed vehicles, including drones.

AI & Machine LearningDefense TechRoboticsUK, GB

Dr. Kelvin Hamilton(Founder & CEO)Dr. Conrad Rider(Co-founder & CTO)Dr. Carl Sequeira(Interim CTO)GMGavin McEwan(Finance Director)in

Co-investorsOXOxford Investment Opportunity Network (OION)

Genevation develops personalized mRNA cancer vaccines using an AI-driven neoantigen discovery platform and cell-free manufacturing, with pre-clinical programs targeting lung, colon, and skin cancers.

AI & Machine LearningBiotechHealthtechStevenage, GB

Able Rehab is a digital therapy platform that uses gamified activities to train hand and wrist movements for patients in rehabilitation.

Digital HealthHealthtechMedical Devices

MMMike Mace(Founder)in

Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.

BiotechCleantechNew MaterialsThame, GB

William Barton(Promoter)Kylie Vincent(Promoter)Holly Reeve(Executive Officer, Director)inMatthew Hodges(Executive Officer)inJose De Sousa(Director)Kevin Matthews(Director)in

Co-investorsCLClean Growth FundFUFuture Planet CapitalOXOxford Investment Opportunity Network (OION)UKUK Innovation & Science Seed Fund

Lucida Medical develops AI software to detect clinically significant prostate cancer from MRI scans, helping radiologists and physicians identify cancers, rule out patients who need no further investigation, and speed up the diagnostic pathway.

AI & Machine LearningDigital HealthMedical Devices

Antony Rix(Founder)inAnwar Padhani(Chief Medical Officer)

Co-investorsCOConduit ConnectIWIW CapitalOXOxford Investment Opportunity Network (OION)THThe FSE GroupXTXTX Markets

Mach42 develops AI tools for high-performance computing tasks, including analog circuit simulation and test plan development for semiconductors as well as real-time fusion control mechanisms.

AI & Machine LearningDeep TechSemiconductors

Co-investorsBUBusiness Growth FundFOForesight Group

Metacarpal builds body-powered, multi-articulating upper-limb prosthetic hands designed to be waterproof, durable, and reliable without charging.

HardwareHealthtechMedical Devices

Co-investorsGAGabriel Investment SyndicateOXOxfordSCScottish Enterprise

Metal Powder and Process Ltd develops and manufactures metal powders for critical manufacturing applications, offering gas atomised powders with tailored particle size distributions and optimised morphology.

Advanced ManufacturingHardwareNew Materials

MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections.

BiotechDeep TechHealthtechSheffield, GB

KLKirsty Louise Smitten(Co-founder and first CEO)Professor Jim Thomas(Chief Scientific Advisor & Co-Founder)DMDr Michael Murray(CEO)in

Co-investorsSESeedrs

MitoRx develops first-in-class, targeted small-molecule therapies that restore mitochondrial health to treat people with high-risk, metabolically unhealthy obesity and related cardiometabolic diseases.

BiotechHealthtechLongevityHarwell Oxford, GB

JRJon R.(Founder)inJon Rees PhD(Co-founder & Chief Executive Officer)Norman Law PhD(Co-founder, Chief Technology Officer & Head of Intellectual Property)

Co-investorsFUFuture Planet CapitalOXOxford Investment Opportunity Network (OION)UKUK Innovation & Science Seed FundEMEmpirical VenturesWRWren Capital

Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection.

AI & Machine LearningDeep TechHealthtechMedical Devices

MKMonika Kott(Co-Founder & CEO)inBVBabar Vaqas(Co-Founder & CMO)in

Co-investorsZIZinc

Nikalyte manufactures physical vapor deposition (PVD) systems and instruments for thin-film and nanoparticle deposition serving research institutions, universities, and industrial customers.

AI & Machine LearningDeep TechHardwareNew Materials

AKAlistair Kean(Founder)inDMDave Mason(Founder)inSRSrinivasa Rao Saranu(Founder)inMVMark Vaughan(Founder)

ONI develops the Nanoimager, an automated super-resolution imaging system.

BiotechDeep TechHardwareMedical DevicesOxford, GB

Co-investorsANAnjostARARCH Venture PartnersARArtis VenturesFUFuture Planet CapitalVEVertical Venture PartnersAXAxon Ventures+6 more

Orbit Discovery provides peptide discovery solutions for pharmaceutical and biotechnology companies, serving both large pharmaceutical firms and smaller biotech enterprises.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

NBNeil Butt(CEO)in

Co-investorsFUFuture Planet CapitalOXOxford Science EnterprisesPEPerivoli InnovationsBOBorealis Ventures

Unable to determine from the page provided.

BiotechHealthtechMedical DevicesTyler, US

Co-investorsANAnjostBIBig Pi VenturesPEPerivoli InnovationsWIWinton Ventures

OVO Biomanufacturing offers a cloud-based software platform that helps viral vaccine manufacturers manage and reduce defective interfering particles (DIPs) to improve production yields.

Advanced ManufacturingBiotechSaaS

OxVent designs and produces a low-cost electro-mechanical medical ventilator, originally developed for the UK Government's 2020 Ventilator Challenge by engineers and medics from the University of Oxford and King's College London.

HardwareHealthtechMedical Devices

PMProf Mark Thompson(Chair, Co-founder of OxVent)PFProf Federico Formenti(Founding Director, Co-founder of OxVent)Paul Inness(CEO)in

Sustainable laundry service disrupting the traditional cleaning industry.

Co-investorsCOConduit ConnectOXOxford Investment Opportunity Network (OION)SUSustainable VenturesTRTrueSight VenturesVAVala Capital

Pathfinder Bio uses enzyme engineering and low-cost protein production to develop biocatalysts and biotechnological processes for molecular biology reagents, diagnostics, and industrial biomanufacturing.

BiotechCircular EconomyDeep Tech

Polycat develops dry powder formulations that absorb and detoxify highly toxic liquids, including chemical warfare agents (CWAs), for defence, industry, and emergency response users.

CleantechDefense TechNew Materials

Process Vision develops optical measurement and imaging technology for the oil and gas industry, focused on improving process efficiency, reducing maintenance costs, and lowering emissions.

Deep TechEnergyIoTRobotics

PaulPaul Stockwellin

Co-investorsTHThe FSE Group

Revolutionary Concepts Ltd designs and produces oil-free, modular multistage centrifugal air compressors and on-site nitrogen generation systems with patented interstage cooling to cut energy use by roughly 30%.

CleantechEnergyHardware

Refeyn develops mass photometry instruments that measure the mass of individual biomolecules in solution without labels, enabling analysis of protein purity, interactions, and viral vector characterization for research and manufacturing applications.

BiotechDeep TechHardwareMedical DevicesOxford, GB

PKPhilipp Kukura(Founder)DCDan Cole(Chief Scientist and co-founder)inJBJustin Benesch(Co-founder)in

Co-investorsOXOxford Science EnterprisesFOForesight GroupHOHorizons Ventures

Run3D provides gait analysis services aimed at runners looking to improve performance and avoid or recover from injury, along with a Walk3D offering for active walkers seeking to maintain mobility.

HealthtechSports TechWellness & Fitness

Sasets is a form management and data collection platform that enables organizations to create, deploy, and manage digital forms across mobile and desktop devices.

Cloud ComputingConstruction TechEnterprise SoftwareSaaS

SimedX operates an AI-powered intensive care platform that uses clinical data to provide decision support for acute respiratory care in critical care settings.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Surrey Hydrogen develops green hydrogen production technology.

CleantechClimate TechEnergyNew MaterialsDidcot, GB

Dr Bahman Amini Horri(Founder & Advisor)Dakota Johnston(CEO & Founder)

Co-investorsFUFuture Planet CapitalUKUK Innovation & Science Seed Fund

TTP develops the Thermo Trauma Port, a novel patient transfer device for the trauma care pathway, created with a consortium including East Anglian Air Ambulance, University Hospital of Birmingham and the University of Portsmouth.

HardwareHealthtechMedical Devices

MAMary Anne Cordeiro(Founder & CEO)in

Co-investorsANAnglia Capital Group

Veirulence develops first-in-class non-antibiotic small molecule therapeutics that target bacterial virulence factors to treat resistant infections, with an initial focus on the WHO priority pathogen Pseudomonas aeruginosa.

BiotechDeep TechHealthtechLondon, GB

RTRory Triniman, PhD(Founder)in

Zayndu manufactures and operates ActivatedAir™, a proprietary system for controlled environment agriculture that enhances seed treatment and plant growth.

AgTechCleantechDeep TechFoodTechHardware

FIFelipe Iza(Founder)in